类型II的花素血症伴随着精神障碍与多重药物耐药性相结合3降低,病例报告
Hong Zhao1, Xia Yu1, Jinlin Cheng1
1State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, National Clinical Research Center for Infectious Diseases, National Medical Center for Infectious Diseases, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, 310003, China.
这项研究介绍了一名青少年女孩的II型素血病 (CTLN2) 和多药耐药性3 (MDR3) 缺陷的罕见病例. 这些发现突出了MDR3下降表达与CTLN2之间的潜在联系,需要进一步调查.
科学领域:
- 生物化学 生化学
- 遗传学 是一个遗传学.
- 肝病学 肝病学是一种肝病学.
背景情况:
- 二型素血症 (CTLN2) 是一种罕见的代谢障碍.
- 多药耐药性3 (MDR3) 缺乏影响胆汁运输和肝脏健康.
- 同时出现CTLN2和MDR3缺陷是非常罕见的.
更多相关视频
07:35Methods for Studying the Mechanisms of Action of Antipsychotic Drugs in Caenorhabditis elegans
Published on: February 4, 2014
07:05Important Endpoints and Proliferative Markers to Assess Small Intestinal Injury and Adaptation using a Mouse Model of Chemotherapy-Induced Mucositis
Published on: May 12, 2019
相关概念视频
Mania and Antimanic Drugs: Overview
Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance
A study on guinea pigs examined the...
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Desensitization and Tachyphylaxis
